Tetracyclines inhibit protein synthesis by acting on which part of the ribosome?
Which among the following drugs is safest in a patient allergic to penicillin?
What is the most common side effect of miltefosine?
Which drug is used for prophylaxis against Haemophilus influenzae infection?
Which of the following is an approved oral therapy for Leishmaniasis?
Concurrent administration of tetracyclines is most likely to impair the action of which of the following drugs?
What is the recommended duration of oseltamivir treatment for influenza?
All of the following are true regarding penicillin G except?
A young male presents with meningococcal meningitis and allergy to penicillin. Which is the most suitable drug?
What is the drug of choice for prophylaxis of meningococcal meningitis?
Explanation: **Explanation:** **Mechanism of Action (Why A is correct):** Tetracyclines are bacteriostatic antibiotics that inhibit protein synthesis by reversibly binding to the **30S subunit** of the bacterial ribosome. Specifically, they block the attachment of aminoacyl-tRNA to the **A-site** (Acceptor site) on the mRNA-ribosome complex. This prevents the addition of new amino acids to the growing peptide chain, effectively halting bacterial growth. **Analysis of Incorrect Options:** * **B & C (50S Ribosome):** The 50S subunit is the target for other drug classes, most notably **Macrolides** (Erythromycin, Azithromycin), **Chloramphenicol**, **Clindamycin**, and **Linezolid**. Tetracyclines do not bind to this subunit. * **D (60S Ribosome):** The 60S subunit is a component of the **eukaryotic (human) 80S ribosome**. Tetracyclines are selective for bacterial 70S ribosomes (specifically the 30S portion), which explains their therapeutic index. However, at very high concentrations, they can inhibit mammalian mitochondrial protein synthesis. **NEET-PG High-Yield Pearls:** * **Resistance Mechanism:** The most common mechanism of resistance to Tetracyclines is **active efflux** (via Tet-A pump). * **Contraindications:** They are contraindicated in **pregnancy** and **children <8 years** because they chelate calcium, leading to permanent tooth discoloration and bone growth retardation. * **Drug of Choice:** Doxycycline is the drug of choice for Rickettsial infections (Rocky Mountain Spotted Fever), Chlamydia, Cholera, and Brucellosis. * **Excretion:** Doxycycline is unique as it is primarily excreted via feces and is safe in patients with renal failure.
Explanation: **Explanation:** The correct answer is **Aztreonam**. **Why Aztreonam is the correct choice:** Aztreonam is a **Monobactam**. Unlike other beta-lactams, it possesses a unique monocyclic beta-lactam ring that does not share the common bicyclic nucleus found in penicillins and cephalosporins. Consequently, there is **no cross-reactivity** between Aztreonam and other beta-lactams (except for Ceftazidime, with which it shares a side chain). It is considered the drug of choice when a patient with a documented severe penicillin allergy requires coverage for Gram-negative aerobic bacteria. **Why the other options are incorrect:** * **Cephalexin (1st Gen Cephalosporin) & Cefepime (4th Gen Cephalosporin):** Cephalosporins share a similar structural nucleus with penicillins. In patients with a history of Type-1 hypersensitivity (anaphylaxis) to penicillin, there is a significant risk (approx. 1-10%) of cross-reactivity. * **Imipenem (Carbapenem):** Carbapenems also share a bicyclic ring structure. While the cross-reactivity rate is lower than previously thought (around 1%), it is still significantly higher than that of Aztreonam, making it less "safe" in the context of this question. **High-Yield Clinical Pearls for NEET-PG:** * **Spectrum of Aztreonam:** It is active **only against Gram-negative aerobes** (e.g., *Pseudomonas*, *E. coli*). It has no activity against Gram-positives or anaerobes ("Aztreonam is a Lone Ranger against Gram-negatives"). * **Exception to the Rule:** Aztreonam should be avoided in patients allergic to **Ceftazidime** due to identical side chains. * **Safe Alternatives:** For penicillin-allergic patients, Macrolides (Erythromycin) or Clindamycin are often used for Gram-positive coverage, while Aztreonam is used for Gram-negative coverage.
Explanation: **Explanation:** **Miltefosine** is a landmark drug in the treatment of Leishmaniasis as it is the **first and only oral agent** effective against Visceral Leishmaniasis (Kala-azar). It is an alkylphosphocholine analogue that acts by interfering with cell membrane signaling and inducing apoptosis in the *Leishmania* parasite. 1. **Why Option A is correct:** The most frequent adverse effects of miltefosine are **gastrointestinal (GI) disturbances**. Approximately 40–60% of patients experience **vomiting and diarrhea**. These symptoms are usually dose-dependent, occur early in the treatment course, and are generally transient or manageable with antiemetics and hydration. 2. **Why other options are incorrect:** * **Dermatitis (B):** While skin rashes can occur, they are rare and not the primary side effect. * **Hepatotoxicity (C):** Transient elevations in liver enzymes (ALT/AST) can occur, but this is significantly less common than GI distress. * **Nephrotoxicity (D):** Miltefosine can cause a transient rise in creatinine levels, but it is not primarily known for nephrotoxicity (unlike Amphotericin B, another drug used for Leishmaniasis). **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** Miltefosine is strictly **contraindicated in pregnancy** due to its potent teratogenic effects. Female patients of reproductive age must use effective contraception during and for **5 months after** treatment (due to the drug's long half-life). * **Drug of Choice:** It is a primary treatment for both Visceral and Post-Kala-azar Dermal Leishmaniasis (PKDL). * **Mechanism:** It inhibits **phospholipase C** and protein kinase C, disrupting the parasite's lipid metabolism.
Explanation: **Explanation:** **Rifampicin** is the drug of choice for the prophylaxis of *Haemophilus influenzae* type b (Hib) infection. The primary goal of prophylaxis is to eliminate the nasopharyngeal carriage of the bacteria, thereby preventing the spread to susceptible individuals and reducing the risk of invasive disease (like meningitis or epiglottitis). Rifampicin is highly effective because it achieves high concentrations in respiratory secretions, effectively eradicating the carrier state. **Analysis of Options:** * **Rifampicin (Correct):** It is administered to all household contacts (if there is at least one unvaccinated child <4 years) to prevent secondary cases. The standard adult dose is 600 mg once daily for 4 days. * **Doxycycline:** While a broad-spectrum tetracycline, it is not used for Hib prophylaxis. It is more commonly used for prophylaxis in conditions like Malaria or Leptospirosis. * **Erythromycin:** This macrolide is the drug of choice for prophylaxis against *Bordetella pertussis* (Whooping cough) and *Corynebacterium diphtheriae*, but it is ineffective for eradicating the *H. influenzae* carrier state. **High-Yield Clinical Pearls for NEET-PG:** * **Meningococcal Prophylaxis:** Rifampicin is also used for prophylaxis against *Neisseria meningitidis* (Dose: 600 mg BID for 2 days). * **Mechanism of Action:** Rifampicin inhibits bacterial **DNA-dependent RNA polymerase**. * **Side Effect:** Warn patients about the **orange-red discoloration** of urine, sweat, and tears. * **Contraindication:** It is a potent **enzyme inducer** (CYP450), leading to numerous drug interactions (e.g., reducing the efficacy of oral contraceptives).
Explanation: **Explanation:** **Miltefosine** is the correct answer as it is currently the **only approved oral drug** for the treatment of both Visceral Leishmaniasis (Kala-azar) and Cutaneous Leishmaniasis [2]. Originally developed as an anticancer agent, it acts by inhibiting protein kinase C and phospholipase B, leading to apoptosis-like cell death in the *Leishmania* parasite [2]. Its oral bioavailability makes it a landmark therapy, especially in resource-limited settings where parenteral administration is difficult. **Analysis of Incorrect Options:** * **Sodium Stibogluconate (Option A):** A pentavalent antimonial that was the first-line treatment for decades [3]. It must be administered **intravenously or intramuscularly**. Its use has declined significantly due to widespread resistance (especially in Bihar, India) and cardiotoxicity [3]. * **Pentamidine (Option B):** An aromatic diamidine used as a second-line agent. It is administered **parenterally** [4] and is associated with significant toxicities, including insulin-dependent diabetes mellitus and hypotension. * **Amphotericin B (Option D):** A polyene antibiotic that is highly effective against Leishmania [1]. While Liposomal Amphotericin B is the current **drug of choice** for Kala-azar due to high cure rates, it must be administered via **slow intravenous infusion** [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** Miltefosine is strictly contraindicated in pregnancy [2]. Women of childbearing age must use effective contraception during and for 3-5 months after treatment. * **Drug of Choice:** Liposomal Amphotericin B (L-AmB) is the preferred treatment in India (single dose 10mg/kg) [3]. * **Post-Kala-azar Dermal Leishmaniasis (PKDL):** Miltefosine is also used in the management of PKDL, typically requiring a longer duration of therapy (12 weeks).
Explanation: ### Explanation **The Core Concept: Bacteriostatic vs. Bactericidal Interference** The correct answer is **Penicillin** because of a classic pharmacological antagonism. Penicillins are **bactericidal** agents that act by inhibiting cell wall synthesis. Crucially, they are most effective against bacteria that are actively multiplying and synthesizing new cell walls. **Tetracyclines**, on the other hand, are **bacteriostatic** drugs; they inhibit protein synthesis (30S subunit), which halts bacterial growth and multiplication. When administered concurrently, Tetracyclines stop the bacteria from dividing. Since the bacteria are no longer actively growing, the "target" for Penicillin (active cell wall synthesis) is removed, thereby significantly impairing Penicillin's efficacy. **Analysis of Incorrect Options:** * **A, B, and C (Lincomycin, Chloramphenicol, Erythromycin):** All three are primarily **bacteriostatic** protein synthesis inhibitors (acting on the 50S subunit). While combining different bacteriostatic drugs can sometimes lead to competition for binding sites (e.g., Macrolides and Chloramphenicol), they do not exhibit the same fundamental antagonism seen between a bacteriostatic and a bactericidal agent. **High-Yield NEET-PG Pearls:** * **The Rule of Thumb:** Avoid combining bacteriostatic drugs (Tetracyclines, Sulfonamides, Ethambutol) with bactericidal drugs (Penicillins, Cephalosporins, Aminoglycosides) unless specifically indicated (e.g., in TB or H. pylori treatment). * **Clinical Example:** This antagonism was historically proven in the treatment of pneumococcal meningitis, where the combination of Penicillin and Chlortetracycline resulted in higher mortality than Penicillin alone. * **Exception:** Aminoglycosides (bactericidal) are often combined with Beta-lactams (bactericidal) for **synergy** (e.g., in Enterococcal endocarditis).
Explanation: **Explanation:** **Oseltamivir** is a neuraminidase inhibitor used for the treatment and prophylaxis of Influenza A and B. 1. **Why 5 days is correct:** For the **treatment** of uncomplicated acute influenza, the standard FDA-approved and WHO-recommended regimen is **75 mg twice daily for 5 days**. The drug works by inhibiting the neuraminidase enzyme, preventing the release of new viral particles from infected host cells. Clinical trials demonstrate that a 5-day course is sufficient to significantly reduce the duration of symptoms and viral shedding if initiated within 48 hours of symptom onset. 2. **Why other options are incorrect:** * **7 days:** This is not the standard treatment duration. However, 7 to 10 days is the recommended duration for **chemoprophylaxis** (once-daily dosing) following exposure. * **9 days:** There is no clinical guideline supporting a 9-day regimen for influenza. * **14 days:** This duration is generally reserved for severely immunocompromised patients or those with severe/complicated influenza (e.g., viral pneumonia) where viral replication may be prolonged. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Competitive inhibition of **Neuraminidase**, preventing viral progeny release (budding). * **Timing:** Most effective when started within **48 hours** of symptom onset ("The Golden Window"). * **Pregnancy:** Oseltamivir is the preferred antiviral for pregnant women with influenza. * **Side Effects:** Most common are GI upset (nausea/vomiting) and rare neuropsychiatric events (confusion, self-injury), especially in children. * **Alternative:** **Zanamivir** is administered via inhalation (avoid in asthmatics); **Baloxavir marboxil** is a newer single-dose prodrug (cap-dependent endonuclease inhibitor).
Explanation: **Explanation:** The correct answer is **A**, as it is the only false statement among the options. **1. Why Option A is the correct answer (False statement):** Probenecid does not increase the *duration of action* of Penicillin G; rather, it increases its **plasma concentration (peak levels)**. Probenecid competes with penicillin for the organic anion transporter (OAT) in the renal tubules, thereby inhibiting the active tubular secretion of penicillin. While this results in higher blood levels, it does not significantly prolong the clinical duration of action in a way that changes dosing intervals (unlike repository forms like Procaine or Benzathine penicillin). **2. Analysis of Incorrect Options (True statements):** * **Option B:** Penicillin G (Benzylpenicillin) is the prototype natural penicillin. It has a narrow spectrum primarily targeting **Gram-positive cocci** (Streptococci, Staphylococci - non-beta-lactamase producing) and Gram-positive bacilli (Bacillus anthracis, Corynebacterium). * **Option C:** The basic nucleus of penicillin is **6-aminopenicillanic acid (6-APA)**. The enzyme **amidase** (produced by certain bacteria or used industrially) cleaves the side chain of Penicillin G to produce 6-APA, which is the starting point for semi-synthetic penicillins. * **Option D:** Penicillins are beta-lactam antibiotics that **inhibit cell wall synthesis** by binding to Penicillin-Binding Proteins (PBPs). This inhibits the transpeptidation reaction, preventing cross-linking of peptidoglycan chains, leading to bacterial lysis. **Clinical Pearls for NEET-PG:** * **Repository Penicillins:** To increase the *duration of action*, Penicillin G is formulated as **Procaine Penicillin** (24 hours) or **Benzathine Penicillin** (3–4 weeks). * **Excretion:** 90% of Penicillin G is excreted via tubular secretion; only 10% via glomerular filtration. * **Drug of Choice:** Penicillin G remains the drug of choice for **Syphilis** (Treponema pallidum), Gas gangrene, and Anthrax.
Explanation: **Explanation:** The management of meningococcal meningitis in a patient with a **penicillin allergy** requires an antibiotic that achieves high cerebrospinal fluid (CSF) concentrations and covers *Neisseria meningitidis*. **Why Chloramphenicol is correct:** Chloramphenicol is highly lipid-soluble, allowing it to cross the blood-brain barrier effectively, reaching therapeutic levels in the CSF even without active inflammation. It is primarily bacteriostatic but acts **bactericidal** specifically against the three most common causes of bacterial meningitis: *N. meningitidis*, *S. pneumoniae*, and *H. influenzae*. Due to its distinct chemical structure, it does not cross-react with penicillins, making it the classic alternative for meningococcal meningitis in allergic patients. **Why the other options are incorrect:** * **Meropenem:** While it has excellent CNS penetration, it is a Carbapenem (a Beta-lactam). There is a risk of cross-reactivity in patients with severe penicillin allergies (Type I hypersensitivity). * **Ciprofloxacin:** While used for **prophylaxis** of meningococcal meningitis in close contacts, it is not the drug of choice for the treatment of active meningitis due to inferior clinical efficacy compared to standard agents. * **Teicoplanin:** This is a glycopeptide (similar to Vancomycin) that targets Gram-positive organisms (like MRSA). It has no activity against *N. meningitidis*, which is a Gram-negative diplococcus. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** For Meningococcal meningitis, the DOC is **Ceftriaxone** or Penicillin G. * **Prophylaxis:** The DOC for prophylaxis of meningococcal meningitis is **Rifampicin** (Ciprofloxacin or Ceftriaxone are alternatives). * **Toxicity:** Remember Chloramphenicol is associated with **Bone Marrow Suppression** (dose-dependent) and **Aplastic Anemia** (idiosyncratic), as well as **Gray Baby Syndrome** in neonates.
Explanation: **Explanation:** The primary goal of prophylaxis in meningococcal meningitis is to eradicate the nasopharyngeal carriage of *Neisseria meningitidis* in close contacts, thereby preventing the spread of the disease. **Why Rifampicin is the Correct Answer:** Rifampicin is considered the drug of choice for chemoprophylaxis because it achieves high concentrations in salivary and respiratory secretions, effectively eliminating the carrier state. It is typically administered for 2 days (600 mg twice daily in adults). While Ceftriaxone (IM) and Ciprofloxacin (single dose) are also highly effective alternatives, Rifampicin remains the classic textbook answer for NEET-PG. **Analysis of Incorrect Options:** * **A. Penicillin:** While Penicillin G is a treatment of choice for active meningococcal disease, it does not eliminate the nasopharyngeal carrier state effectively and is therefore not used for prophylaxis. * **B. Erythromycin:** This macrolide has poor efficacy in eradicating *N. meningitidis* from the nasopharynx compared to Rifampicin. * **C. Septran (TMP-SMX):** Resistance to sulfonamides is widespread among meningococci, making Septran unreliable for this indication. **Clinical Pearls for NEET-PG:** * **Drug of Choice for Treatment:** Ceftriaxone or Penicillin G. * **Prophylaxis in Pregnancy:** Ceftriaxone (IM) is the preferred agent as Rifampicin and Ciprofloxacin are generally avoided. * **Side Effect Note:** Warn patients that Rifampicin may cause orange-red discoloration of urine, sweat, and tears. * **Ciprofloxacin:** A single 500 mg dose is an effective alternative for adults but is usually avoided in children and pregnant women.
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free